Advertisement

Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation

Published:December 03, 2015DOI:https://doi.org/10.1016/j.clinimag.2015.11.022

      Abstract

      Objective

      The aim of the study was to investigate the performance of dynamic 3-dimensional contrast-enhanced ultrasound (3D-CEUS) on assessment of efficacy of local ablation therapy of hepatocellular carcinoma (HCC) with contrast-enhanced computed tomography (CT) as reference standard.

      Methods

      Eighty-nine HCC lesions from 75 patients undergoing ultrasound-guided percutaneous thermal ablation or chemical ablation were studied by both dynamic 3D-CEUS and contrast-enhanced CT 1 month after ablation. Imaging results from two imaging modalities were evaluated independently by experienced readers to determine whether the treated lesions were ablated incompletely (residual unablated tumor) or completely. Sensitivity, specificity, positive and negative predictive values, and accuracy to identify incomplete ablation were calculated for dynamic 3D-CEUS imaging with contrast-enhanced CT as reference standard.

      Results

      Contrast-enhanced CT reported that 80.9% (72/89) of all the treated lesions were completely ablated and 19.1% (17/89) were incompletely ablated. The dynamic 3D-CEUS identified 82.0% (73/89) and 18.0% (16/89) of lesions as completely and incompletely ablated, respectively. With contrast-enhanced CT as the reference standard, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of dynamic 3D-CEUS for identifying residual unablated tumor were 88.2% (15/17), 98.6% (71/72), 93.8% (15/16), 97.3% (71/73), and 96.6% (86/89), respectively. The Kappa value for identifying residual unablated tumor between contrast-enhanced CT and dynamic 3D-CEUS was 0.89.

      Conclusions

      Dynamic 3D-CEUS is highly consistent with contrast-enhanced CT in assessment of efficacy of HCC ablation and has potential to serve as an alternative to contrast-enhanced CT in the follow-up assessment after HCC ablation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ferlay J
        • Soerjomataram I
        • Dikshit R
        • Eser S
        • Mathers C
        • Rebelo M
        • et al.
        Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
        Int J Cancer. 2015; 136: E359-E386
        • Butros SR
        • Shenoy-Bhangle A
        • Mueller PR
        • Arellano RS
        Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasibility, local tumor control, and long-term outcome.
        Clin Imaging. 2014; 38: 490-494
        • Tombesi P
        • Di Vece F
        • Sartori S
        Resection vs thermal ablation of small hepatocellular carcinoma: what’s the first choice?.
        World J Radiol. 2013; 5: 1-4
        • Cucchetti A
        • Piscaglia F
        • Cescon M
        • Ercolani G
        • Pinna AD
        Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma.
        World J Gastroenterol. 2013; 19: 4106-4118
        • Panpikoon T
        • Treesit T
        • Thapaneeyakorn J
        • Wedsart B
        • Inman T
        Efficacy of percutaneous radiofrequency ablation of hepatic malignant tumors using a perfused-cooled electrode.
        J Med Assoc Thai. 2013; 96: 77-82
        • Ding J
        • Jing X
        • Liu J
        • Wang Y
        • Wang F
        • Wang Y
        • et al.
        Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques.
        Clin Radiol. 2013; 68: 608-615
        • Kang TW
        • Lim HK
        • Lee MW
        • Kim YS
        • Choi D
        • Rhim H
        First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up.
        Clin Radiol. 2013; 68: e641-e651
        • Salvaggio G
        • Campisi A
        • Lo Greco V
        • Cannella I
        • Meloni MF
        • Caruso G
        Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
        Abdom Imaging. 2010; 35: 447-453
        • Inoue T
        • Kudo M
        • Hatanaka K
        • Arizumi T
        • Takita M
        • Kitai S
        • et al.
        Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
        Oncology. 2013; 84: 51-57
        • Toshikuni N
        • Shiroeda H
        • Ozaki K
        • Matsue Y
        • Minato T
        • Nomura T
        • et al.
        Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma.
        Radiol Oncol. 2013; 47: 224-229
        • Xu HX
        • Lu MD
        The current status of contrast-enhanced ultrasound in China.
        J Med Ultrason. 2010; 37: 97-106
        • Sporea I
        • Badea R
        • Martie A
        • Dumitru E
        • Ioaniţescu S
        • Sirli R
        • et al.
        Contrast enhanced ultrasound for the evaluation of focal liver lesions in daily practice. A multicentre study.
        Med Ultrason. 2012; 14: 95-100
        • Dietrich CF
        3D real time contrast enhanced ultrasonography: a new technique.
        Röfo. 2002; 174: 160-163
        • Ohto M
        • Kato H
        • Tsujii H
        • Maruyama H
        • Matsutani S
        • Yamagata H
        Vascular flow patterns of hepatic tumors in contrast-enhanced 3-dimensional fusion ultrasonography using plane shift and opacity control modes.
        J Ultrasound Med. 2005; 24: 49-57
        • Yukisawa S
        • Ohto M
        • Masuya Y
        • Okabe S
        • Fukuda H
        • Yoshikawa M
        • et al.
        Contrastenhanced three-dimensional fusion sonography of small liver metastases with pathologic correlation.
        J Clin Ultrasound. 2007; 35: 1-8
        • Forsberg F
        • Rawool NM
        • Merton DA
        • Liu JB
        • Goldberg BB
        Contrast enhanced vascular three-dimensional ultrasound imaging.
        Ultrasonics. 2002; 40: 117-122
        • Levey AS
        • Atkins R
        • Coresh J
        • Cohen EP
        • Collins AJ
        • Eckardt KU
        • et al.
        Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes.
        Kidney Int. 2007; 72: 247-259
        • Claudon M
        • Dietrich CF
        • Choi BI
        • Cosgrove DO
        • Kudo M
        • Nolsøe CP
        • et al.
        Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
        Ultraschall Med. 2013; 34: 11-29
        • Luo W
        • Numata K
        • Morimoto M
        • Oshima T
        • Ueda M
        • Okada M
        • et al.
        Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
        Eur J Radiol. 2010; 75: 91-97
        • Clevert DA
        • D’Anastasi M
        • Jung EM
        Contrast-enhanced ultrasound and microcirculation: efficiency through dynamics—current developments.
        Clin Hemorheol Microcirc. 2013; 53: 171-186
        • Xu HX
        • Yin XY
        • Lu MD
        • Xie XY
        • Xu ZF
        • Liu GJ
        Usefulness of three-dimensional sonography in procedures of ablation for liver cancers: initial experience.
        J Ultrasound Med. 2003; 22: 1239-1247
        • Rose SC
        • Hassanein TI
        • Easter DW
        • Gamagami RA
        • Bouvet M
        • Pretorius DH
        • et al.
        Value of three-dimensional US for optimizing guidance for ablating focal liver tumors.
        J Vasc Interv Radiol. 2001; 12: 507-515
        • Luo W
        • Numata K
        • Morimoto M
        • Nozaki A
        • Nagano Y
        • Sugimori K
        • et al.
        Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods.
        AJR Am J Roentgenol. 2009; 192: 165-173
        • Xu HX
        • Lu MD
        • Xie XH
        • Xie XY
        • Xu ZF
        • Chen LD
        • et al.
        Three-dimensional contrast-enhanced ultrasound of the liver: experience of 92 cases.
        Ultrasonics. 2009; 49: 377-385
        • Luo W
        • Numata K
        • Morimoto M
        • Nozaki A
        • Ueda M
        • Kondo M
        • et al.
        Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.
        World J Gastroenterol. 2010; 16: 2109-2119
        • Xiang H
        • Huang R
        • Cheng J
        • Gulinaer S
        • Hu R
        • Feng Y
        • et al.
        Value of three-dimensional contrast-enhanced ultrasound in the diagnosis of small adnexal masses.
        Ultrasound Med Biol. 2013; 39: 761-768
        • Shi H
        • Yu XH
        • Guo XZ
        • Guo Y
        • Zhang H
        • Qian B
        • et al.
        Double contrast-enhanced two-dimensional and three-dimensional ultrasonography for evaluation of gastric lesions.
        World J Gastroenterol. 2012; 18: 4136-4144
        • Pezzilli R
        • Serra C
        • Calculli L
        • Ferroni F
        • Iammarino MT
        • Casadei R
        Three-dimensional contrast-enhanced ultrasonography of intraductal papillary mucinous neoplasms of the pancreas: a comparison with magnetic resonance imaging.
        Pancreas. 2013; 42: 1164-1168
        • Luo W
        • Numata K
        • Morimoto M
        • Kondo M
        • Takebayashi S
        • Okada M
        • et al.
        Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT.
        Radiology. 2009; 251: 287-295
        • Zhong-Zhen S
        • Kai L
        • Rong-Qin Z
        • Er-Jiao X
        • Ting Z
        • Ao-Hua Z
        • et al.
        A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma.
        Ultraschall Med. 2012; 33: E250-E255
        • Leen E
        • Kumar S
        • Khan SA
        • Low G
        • Ong KO
        • Tait P
        • et al.
        Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors.
        World J Gastroenterol. 2009; 15: 289-299
        • Bricault I
        • Kikinis R
        • Morrison PR
        • Vansonnenberg E
        • Tuncali K
        • Silverman SG
        Liver metastases: 3D shape-based analysis of CT scans for detection of local recurrence after radiofrequency ablation.
        Radiology. 2006; 241: 243-250
        • Liu GJ
        • Lu MD
        • Xie XY
        • Xu HX
        • Xu ZF
        • Zheng YL
        • et al.
        Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions.
        J Ultrasound Med. 2008; 27: 657-666